Implantable Cardioverter Defibrillators (ICD) Market Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast Report To 2016 Summary GlobalData's Medical Devices sector report, "Implantable Cardioverter Defibrillators (ICD) Medical Devices Pipeline Assessment, 2016" provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. To Get More Details @ http://www.radiantinsights.com/research/implantablecardioverter-defibrillators-icd-medical-devices-pipeline-assessment-2016 Scope - Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to Buy The report enables you to - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date. Table Of Content: Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 7 2 Introduction 8 2.1 Implantable Cardioverter Defibrillators (ICD) Overview 8 3 Products under Development 9 3.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 9 3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 10 3.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 11 3.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 12 3.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 13 3.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 14 To Get Sample Copy of Report visit @ http://www.radiantinsights.com/research/implantable-cardioverter-defibrillators-icdmedical-devices-pipeline-assessment-2016#tabs-4 4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies 15 4.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development 15 4.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 16 5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 17 5.1 AIS Inc. Company Overview 17 5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Biotronik SE & Co. KG Company Overview 18 5.2.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 18 5.3 Boston Scientific Corporation Company Overview 29 5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29 5.4 CardiaLen, Inc. Company Overview 38
5.4.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38 5.5 InnerPulse, Inc. Company Overview 40 5.5.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 5.6 Kenergy Inc. Company Overview 41 5.6.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 41 5.7 Max Planck Institute for Dynamics and Self-Organization Company Overview 42 5.7.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 42 5.8 Medtronic plc Company Overview 43 5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43 5.9 Smartwave Medical Ltd Company Overview 47 5.9.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47 5.10 The Johns Hopkins University Company Overview 48 5.10.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 48 5.11 University of Leicester Company Overview 52 5.11.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 52 Browse Our More Medical Devices Related Reports @ http://www.radiantinsights.com/catalog/medical-devices 6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 54 6.1 Apr 25, 2016: Philips' First Quarter Results 2016 54 6.2 Apr 20, 2016: Boston Scientific Announces CE Mark For MRI Labeling Of Emblem S-ICD Systems 55 6.3 Apr 20, 2016: Boston Scientific Announces CE Mark For MRI Labeling Of Emblem S-ICD Systems 56 6.4 Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment 56 6.5 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 57 6.6 Mar 17, 2016: Medtronic Proposes Proxy Access 57 6.7 Mar 10, 2016: Philips meets stringent U.S. government security requirements for pathology medical data 57 6.8 Mar 09, 2016: Management Changes at ZOLL Signal Stable Leadership and Steady Growth 58 6.9 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 59 6.10 Feb 22, 2016: Philips to introduce next-generation monitoring solution enabled by wearable biosensors 60 6.11 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 61 6.12 Feb 11, 2016: BIOTRONIK Announces CE Approval for new series of ICDs and CRT-Ds with MRI AutoDetect 61 6.13 Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification 62 6.14 Jan 27, 2016: CONMED Announces Fourth Quarter and Fiscal Year 2015 Financial Results 62
6.15 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 63 6.16 Jan 11, 2016: HeartWare International Provides Corporate Updates And Announces Preliminary Revenue For Fourth Quarter 2015 64 6.17 Jan 05, 2016: Philips wants you to be the picture of health: showcases cloud-based technologies for every stage of life at CES 65 6.18 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 66 6.19 Dec 21, 2015: Medtronic Receives First Health Canada License for MRI Conditional Implantable Cardioverter Defibrillator System 67 6.20 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 68 6.21 Nov 23, 2015: Philips partnership with the RSNA Research & Education Foundation awards more than 110 grant recipients since 1991 69 6.22 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 70 6.23 Nov 02, 2015: LivaNova Announces the Launch of the PLATINIUM ICD & CRT-D Family Providing the World's Longest Projected Longevity 70 6.24 Oct 30, 2015: Nearly 500 Hospitals Pay United States More Than $250 Million to Resolve False Claims Act Allegations Related to Implantation of Cardiac Devices 71 6.25 Oct 29, 2015: HeartWare International Reports Third Quarter 2015 Results 72 6.26 Oct 21, 2015: CONMED Announces Third Quarter 2015 Financial Results 73 6.27 Oct 01, 2015: World's First and Only ICD Offering 3 Tesla MRI Access Launched in Japan 74 For Further Inquiries: http://www.radiantinsights.com/research/implantable-cardioverterdefibrillators-icd-medical-devices-pipeline-assessment-2016 6.28 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 75 6.29 Sep 15, 2015: Philips provides update on its performance trajectory and strategy to capture the opportunities in the HealthTech market at its Capital Markets Day 75 6.30 Sep 14, 2015: Medtronic First To Receive FDA Approval For MR-Conditional Implantable Cardioverter Defibrillator System 76 6.31 Sep 13, 2015: Physio-Control to Acquire HeartSine Technologies 77 6.32 Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova's Chief Financial Officer 77 6.33 Sep 08, 2015: No Further Legal Action By Italian State's Attorney To Enjoin The Combination Of Sorin And Cyberonics 77 6.34 Sep 04, 2015: NORDIC ICD Trial Calls Defibrillation Testing during ICD Implantation into Question 78 6.35 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 78 6.36 Sep 03, 2015: Philips introduces personal health programs at IFA in Berlin 81 6.37 Sep 02, 2015: Philips Healthcare Receives DOD Contract For Biomedical Equipment 82 6.38 Aug 31, 2015: Medtronic Study Detects Gene Associated with Sudden Cardiac Death 82
6.39 Aug 09, 2015: Philips Healthcare India Plans To Invest $60m To Double Production Capacity At Pune Facility 83 6.40 Aug 07, 2015: Financial Results for the First Quarter of Fiscal Year Ending March 31, 2016 84 6.41 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 86 7 Appendix 116 7.1 Methodology 116 7.2 About GlobalData 118 7.3 Contact Us 119 7.4 Disclaimer 119 About Us Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of Ancillary services such as, research partnerships/ tie-ups and customized research solutions. Media Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Website: Radiant Insights Visit Our Blog: radiantri.blogspot.com